The INDICAID® COVID-19 Rapid Antigen Test (FDA EUA) is a lateral flow immunoassay designed for the qualitative detection of SARS-CoV-2 antigens in direct nasal swab samples. Quick: With INDICAID®, users can expect quick results in just 20 minutes. Easy: User-friendly testing. No additional equipment or training is required. Simple Sampling: INDICAID® comes with intuitive vials to obtain self-collected shallow nasal samples.